533 related articles for article (PubMed ID: 23622795)
1. Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: added value of diffusion-weighted MRI.
Kang TW; Kim SH; Park HJ; Lim S; Jang KM; Choi D; Lee SJ
Clin Radiol; 2013 Oct; 68(10):992-1001. PubMed ID: 23622795
[TBL] [Abstract][Full Text] [Related]
2. Added value of diffusion-weighted MR imaging in the diagnosis of ampullary carcinoma.
Jang KM; Kim SH; Lee SJ; Park HJ; Choi D; Hwang J
Radiology; 2013 Feb; 266(2):491-501. PubMed ID: 23238154
[TBL] [Abstract][Full Text] [Related]
3. Role of diffusion-weighted magnetic resonance imaging in the diagnosis of gallbladder cancer.
Kim SJ; Lee JM; Kim H; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Jul; 38(1):127-37. PubMed ID: 23281048
[TBL] [Abstract][Full Text] [Related]
4. Xanthogranulomatous cholecystitis: diagnostic performance of US, CT, and MRI for differentiation from gallbladder carcinoma.
Lee ES; Kim JH; Joo I; Lee JY; Han JK; Choi BI
Abdom Imaging; 2015 Oct; 40(7):2281-92. PubMed ID: 25952571
[TBL] [Abstract][Full Text] [Related]
5. CT and MR features of xanthogranulomatous cholecystitis: an analysis of consecutive 49 cases.
Zhao F; Lu PX; Yan SX; Wang GF; Yuan J; Zhang SZ; Wang YX
Eur J Radiol; 2013 Sep; 82(9):1391-7. PubMed ID: 23726123
[TBL] [Abstract][Full Text] [Related]
6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder.
Lee NK; Kim S; Kim TU; Kim DU; Seo HI; Jeon TY
Clin Radiol; 2014 Feb; 69(2):e78-85. PubMed ID: 24290779
[TBL] [Abstract][Full Text] [Related]
8. Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer.
Suzuki H; Wada S; Araki K; Kubo N; Watanabe A; Tsukagoshi M; Kuwano H
World J Gastroenterol; 2015 Sep; 21(35):10166-73. PubMed ID: 26401081
[TBL] [Abstract][Full Text] [Related]
9. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
10. Strategies for diagnosis of xanthogranulomatous cholecystitis masquerading as gallbladder cancer.
Zhang LF; Hou CS; Liu JY; Xiu DR; Xu Z; Wang LX; Ling XF
Chin Med J (Engl); 2012 Jan; 125(1):109-13. PubMed ID: 22340475
[TBL] [Abstract][Full Text] [Related]
11. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
Park HJ; Kim SH; Jang KM; Lim S; Kang TW; Park HC; Choi D
AJR Am J Roentgenol; 2014 Jan; 202(1):92-101. PubMed ID: 24370133
[TBL] [Abstract][Full Text] [Related]
12. Xanthogranulomatous cholecystitis--a diagnostic challenge.
Jetley S; Rana S; Khan RN; Jairajpuri ZS
J Indian Med Assoc; 2012 Nov; 110(11):833-7. PubMed ID: 23785925
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted magnetic resonance imaging to differentiate malignant from benign gallbladder disorders.
Kitazume Y; Taura S; Nakaminato S; Noguchi O; Masaki Y; Kasahara I; Kishino M; Tateishi U
Eur J Radiol; 2016 Apr; 85(4):864-73. PubMed ID: 26971436
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of xanthogranulomatous cholecystitis.
Furuta A; Ishibashi T; Takahashi S; Sakamoto K
Radiat Med; 1996; 14(6):315-9. PubMed ID: 9132812
[TBL] [Abstract][Full Text] [Related]
15. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases.
Deng YL; Cheng NS; Zhang SJ; Ma WJ; Shrestha A; Li FY; Xu FL; Zhao LS
World J Gastroenterol; 2015 Nov; 21(44):12653-9. PubMed ID: 26640342
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of malignant from benign focal splenic lesions: added value of diffusion-weighted MRI.
Jang KM; Kim SH; Hwang J; Lee SJ; Kang TW; Lee MW; Choi D
AJR Am J Roentgenol; 2014 Oct; 203(4):803-12. PubMed ID: 25247945
[TBL] [Abstract][Full Text] [Related]
17. Differentiating hepatic abscess from malignant mimickers: value of diffusion-weighted imaging with an emphasis on the periphery of the lesion.
Park HJ; Kim SH; Jang KM; Lee SJ; Park MJ; Choi D
J Magn Reson Imaging; 2013 Dec; 38(6):1333-41. PubMed ID: 23559325
[TBL] [Abstract][Full Text] [Related]
18. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
19. [Clinico-pathological study of xanthogranulomatous cholecystitis].
Kitagawa S; Nakagawa M; Yamada T; Mori Y; Simizu H; Rin S; Kurumaya H
Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1001-10. PubMed ID: 2233654
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI for differential diagnosis in gallbladder lesions with special reference to ADC cut-off values.
Yoshioka M; Watanabe G; Uchinami H; Miyazawa H; Abe Y; Ishiyama K; Hashimoto M; Nakamura A; Yamamoto Y
Hepatogastroenterology; 2013 Jun; 60(124):692-8. PubMed ID: 24046830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
